Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
3.130
+0.080 (2.62%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $203.21 million as of April 23, 2024. Its market cap has increased by 10.44% in one year.
Market Cap
203.21M
Enterprise Value
75.15M
1-Year Change
10.44%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $203.21M, a decrease of -80.66%. That is a compound annual growth rate of -43.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 197.70M | -1.30% |
Apr 19, 2024 | 200.30M | 3.89% |
Apr 18, 2024 | 192.80M | 4.73% |
Apr 17, 2024 | 184.10M | -9.53% |
Apr 16, 2024 | 203.50M | -14.46% |
Apr 15, 2024 | 237.90M | -6.12% |
Apr 12, 2024 | 253.40M | -3.47% |
Apr 11, 2024 | 262.50M | 7.14% |
Apr 10, 2024 | 245.00M | -5.73% |
Apr 9, 2024 | 259.90M | 6.08% |
Apr 8, 2024 | 245.00M | 4.12% |
Apr 5, 2024 | 235.30M | -0.25% |
Apr 4, 2024 | 235.90M | -1.63% |
Apr 3, 2024 | 239.80M | -2.40% |
Apr 2, 2024 | 245.70M | -6.40% |
Apr 1, 2024 | 262.50M | -3.10% |
Mar 28, 2024 | 270.90M | -2.13% |
Mar 27, 2024 | 276.80M | 7.29% |
Mar 26, 2024 | 258.00M | -0.73% |
Mar 25, 2024 | 259.90M | -9.47% |
Mar 22, 2024 | 287.10M | -7.33% |
Mar 21, 2024 | 309.80M | -4.59% |
Mar 20, 2024 | 324.70M | 4.37% |
Mar 19, 2024 | 311.10M | 1.04% |
Mar 18, 2024 | 307.90M | -5.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Trevi Therapeutics | 202.74M |
Abeona Therapeutics | 201.33M |
Codexis | 201.07M |
Zevra Therapeutics | 198.46M |
Rigel Pharmaceuticals | 198.18M |
Elevation Oncology | 197.04M |
Cardiff Oncology | 194.79M |
INmune Bio | 193.41M |